Chemkart India IPO Details

Incorporated in 2015, Chemkart India Limited is a Mumbai-based B2B distributor specializing in high-quality food and health ingredients. The company acts as a strategic link between global ingredient manufacturers and businesses across diverse sectors, including nutraceuticals, sports nutrition, and wellness.

Core Business and Capabilities

Focused on the B2B segment, Chemkart supplies essential ingredients used in the formulation of dietary supplements—ranging from sports and health supplements to vitamins and proteins. The company emphasizes variety, affordability, quality, and strong client relationships, playing a key role in optimizing the supply chain for its customers.

Chemkart operates a modern processing and warehousing facility in Bhiwandi, Maharashtra, spanning approximately 28,259 sq. ft. The facility supports in-house grinding, blending, labeling, packaging, and sealing services in a hygienic, quality-controlled environment. With annual blending and grinding capacities of 450 metric tons and 540 metric tons respectively, Chemkart delivers tailored ingredient solutions, including specialized amino acids like L-Leucine Instant and L-Histidine.

Product Portfolio

Chemkart’s offerings are organized into seven primary categories:

• Amino Acids: Fundamental protein components crucial for metabolism and biological processes.
• Health Supplements: Formulations enriched with essential nutrients and bioactive compounds for overall well-being.
• Herbal Extracts: Plant-based extracts used for their therapeutic and functional benefits.
• Nucleotides: Bioactive molecules supporting immune function, digestive health, and cellular nutrition.
• Proteins: Key macronutrients for muscle repair, immune response, and bodily functions.
• Sports Nutrition: Performance-focused ingredients that aid in endurance, energy, and recovery.
• Vitamins: Essential micronutrients necessary for numerous physiological activities.

Financial Highlights

For the fiscal year ending March 31, 2024, Chemkart reported operating revenue of INR 132.03 crore, marking a steady rise from INR 131.38 crore in FY23 and INR 86.98 crore in FY22. This translates to a CAGR of 23.20% over the FY22–FY24 period.

Competitive Strengths

• Diversified Product Range across high-demand nutritional categories
• In-House Processing and Warehousing, enabling cost and quality control
• Customer-Centric Value Proposition, fostering long-term client relationships

As of January 31, 2025, Chemkart employed 31 personnel. The company maintains a robust domestic footprint while also serving international markets, reinforcing its position in India's rapidly expanding nutraceutical landscape.